Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes: A target-specific effect or response to a low-frequency pattern of stimulation?

Clinical EEG and Neuroscience

Volumn 41, Issue 2, 2010, Pages 82-86

  Stefani, A ^a,b   Pierantozzi, M ^a   Ceravolo, R ^c   Brusa, L ^d   Galati, S ^a   Stanzione, Paolo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

Author keywords

Deep brain stimulation; Low frequency stimulation; Parkinson's disease; Pedunculopontine tegmental area; Positron Emission Tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITION; CORPUS STRIATUM; FRONTAL CORTEX; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; LIMBIC SYSTEM; MOTOR PERFORMANCE; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; TREATMENT RESPONSE;

EID: 77952970323     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005941004100207     Document Type: Article

References (41)

1. Krack P, Batir A, Van Blercom N, et al. Five years follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med 2003; 349: 1925-1934. (Pubitemid 37409709)
2. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128: 2240-2249.
3. Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AM, Manrique M. L-DOPA-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 2008; 62: 311-328.
4. Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265-272.
5. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588.
6. Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van Laar T, Schmand B. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006; 66: 1830-1836.
7. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus internal deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.
8. Volkmann J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1154-1161.
9. Mazzone P, Lozano A, Stanzione P, Galati S, Scamati E, Peppe A, Stefani A. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005; 16: 1877-1881. (Pubitemid 41653506)
10. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130: 1596-1607. (Pubitemid 47355911)
11. Papahill H, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 200; 123: 1767-1783.
12. Costa A, Carlesimo GA, Caltagirone C, Mazzone P, Pierantozzi M, Stefani A, Peppe A. Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 64-67.
13. Romigi A, Placidi F, Peppe A, Pierantozzi M, Izzi F, Brusa L, et al. Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease. Eur J Neurol 2008; 15: 64-65. (Pubitemid 351814413)
14. Stefani A, Galati S, Pierantozzi M, Peppe A, Brusa L, Moschella V, et al. Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology. Groenewegen HJ et al. (eds). The Basal Ganglia IX, Advances in Behavioral Biology 2009: 58.
15. Zanini S, Moschella V, Stefani A, Peppe A, Pierantozzi M, Galati S, et al. Grammar improvement following deep brain stimulation of the subthalamic and the pedunculopontine nuclei in advanced Parkinson's disease: a pilot study. Parkinson's Rel Disord 2009; 15: 606-609.
16. Androulidakis AG, Mazzone P, Litvak V, Penny W, Dileone M, Gaynor LM, et al. Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol 2008; 211: 59-66.
17. Lim AS, Mora E, Lozano AM, Hamani C, Dostrovsky JO, Hutchison WD, et al. Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons. Ann Neurol 2009; 66: 110-114.
18. Mazzone P, Sposato S, Insola A, Di Lazzaro V, Scarnati E. Stereotactic surgery of nucleus tegmenti pedunculopontini. Br J Neurosurg 2008; 22: S33-S40.
19. Ceravolo R, Borghetti D, Kiferle L, Tognoni G, Giorgetti A, Neglia D, et al. CSF phosphorylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Res Bull 2008; 76: 80-84.
20. Stefani A, Ceravolo R, Brusa L, Pierantozzi M, Costa A, Galati S, et al. Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains. J Neurol Sci 2010; 289: 44-48.
21. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
22. Fahn S, Elton RL, Members of the UPDRS. Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, et al., (eds). Recent Developments in Parkinson's Disease. New York: Macmillan; 1987: 153-163.
23. Elwood RW. The California Verbal Learning Test: psychometric characteristics and clinical application. Neuropsychol Rev 1995; 5: 173-201. (Pubitemid 26114647)
24. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990; 85: 119-146.
25. Haber SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003; 26: 317-330. (Pubitemid 38077155)
26. Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci 2004; 27: 585-588.
27. Grace AA, Floresco SB, Goto Y, Lodge DJ. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 2007; 30: 220-227. (Pubitemid 46654234)
28. Aouizerate B, Guehl D, Cuny E, Rougier A, Bioulac B, Tignol J, Burbaud P. Pathophysiology of obsessive-compulsive disorder a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004; 72: 195-221. (Pubitemid 38591296)
29. Strafella AP, Lozano AM, Ballanger B, Poon YY, Lang AE, Moro E. rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study. Mov Disord 2008; 23: 1051-1054.
30. Ballanger B, Lozano AM, Moro E, van Eimeren T, Hamani C, Chen R, et al. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp 2009; 30: 3901-3909.
31. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006; 248: 234-250. (Pubitemid 44647310)
32. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006; 129: 2667-2678. (Pubitemid 44522100)
33. R. Hilker, J.Voges, A. Thiel, M. Ghaemi, K. Herholz, V. Sturm, W.D. Heiss. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET. J Neural Transm 2002: 109: 1257-1264.
34. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2007; 24: 7-16.
35. Kalbe E, Voges J, Weber T, Haarer, Baudrexel S, Klein JC, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009: 72: 4249.
36. Campbell MC, Karimi M, Weaver PM, Wu J, Perantie DC, Golchin NA, et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 2008; 46: 3162-3169.
37. Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E, et al. Deep brain stimulation and cognitive functions in Parkinson's disease: a three years controlled study. Mov Disorder 2009; 11: 1621-1628.
38. Schroeder U, Kuehler A, Haslinger B, Erhard P, Fogel W, Tronnier VM, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125: 1995-2004.
39. Haegelen C, García-Lorenzo D, Le Jeune F, Péron J, Gibaud B, Riffaud L,et al. SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation. J Neurol 2009; Sep 23. (Epub ahead of print] PubMed PMID.
40. Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989; 26(1): 41-46.
41. Stefani A, Fedele E, Galati S, Pepicelli O, Frasca S, Pierantozzi M, et al. Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients. Ann Neurol 2005; 57: 448-452.